Clinical Trials Browser

OTHER × Interventional × Breast × Clear all

NCT02744053 2026-04-16

DCE-MRI and MBI in Assessing Tumor Response to Chemotherapy in Patients With Triple Negative Breast Cancer

Phase EARLY_PHASE1 Active not recruiting

Triple Negative Breast Neoplasms

NCT02918474 2026-04-16

Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer

Phase NA Recruiting

Carcinoma, Intraductal, Noninfiltrating

NCT03377387 2026-04-16

Capecitabine 7/7 Schedule With Neratinib in Patients With Metastatic HER2-Positive Breast Cancer

Phase 1/2 Active not recruiting

Breast Neoplasms

NCT03435952 2026-04-16

Pembrolizumab With Intratumoral Injection of Clostridium Novyi-NT

Phase 1 Active not recruiting

BreastGenitourinary

Breast Neoplasms, Urologic Neoplasms

NCT04003038 2026-04-16

Negative Pressure Wound Therapy in Healing Abdominal Incision in Obese Patients Undergoing Breast Reconstruction Surgery

Phase NA Recruiting

Breast Neoplasms, Obesity

NCT04085276 2026-04-16

TORCHLIGHT

Phase 3 Completed

Triple Negative Breast Neoplasms

NCT04125914 2026-04-16

Weight Management and Health Behavior Intervention in Lowering Cancer Risk for BRCA Positive and Lynch Syndrome Families

Phase NA Active not recruiting

BreastGastrointestinal

Breast Cancer, Familial, Colorectal Neoplasms, Hereditary Nonpolyposis

NCT04267796 2026-04-16

Lifestyle Intervention for the Reduction of Breast Cancer Risk in Normal Weight Women

Phase NA Active not recruiting

40 enrolled 9 charts

Breast Neoplasms

NCT05534438 2026-04-16

A Study on Adding Precisely Targeted Radiation Therapy (Stereotactic Body Radiation Therapy) to the Usual Treatment Approach (Drug Therapy) in People With Breast Cancer

Phase 2 Recruiting

Breast Neoplasms

NCT05749588 2026-04-16

FUSCC Refractory TNBC Platform Study (FUTURE2.0)

Phase 2 Recruiting

Triple Negative Breast Neoplasms

NCT06179303 2026-04-16

Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer

Phase 2 Recruiting

Anatomic Stage III Breast Cancer AJCC v8

NCT06545682 2026-04-16

Phase Ib Study of AlpeliSib With PEmbroLizumab in Patients With mEtastatic Breast caNcer or melanomA (SELENA)

Phase 1 Recruiting

BreastDermatologic

Breast Neoplasms, Melanoma

NCT06964802 2026-04-16

The Effect of Cold Salt Water Foot Bath on the Development Of Chemotherapy-Induced Peripheral Neuropathy

Phase NA Recruiting

Breast Neoplasms

NCT07011654 2026-04-16

Study of Naxitamab and Sacituzumab Govitecan in Patients With Metastatic Triple-negative Breast Cancer (TNBC)

Phase 1/2 Recruiting

Triple Negative Breast Neoplasms

NCT07425548 2026-04-16

JOUVENCE

Phase NA Not yet recruiting

Breast Neoplasms

NCT07447414 2026-04-16

LUBRECA

Phase NA Recruiting

Breast Neoplasms

NCT07467824 2026-04-16

PREACT

Phase NA Recruiting

Breast Neoplasms, Motor Activity

NCT07491380 2026-04-16

TDHOME

Phase NA Not yet recruiting

Breast Neoplasms

NCT07533526 2026-04-16

Effects of Instrument-Assisted Constant-Speed Injection Versus Manual Injection on Pain From Large-Volume Subcutaneous Injection of Pertuzumab and Trastuzumab in Breast Cancer: A Randomized, Self-Controlled Study

Phase NA Not yet recruiting

Breast Neoplasms, Pain

NCT02095184 2026-04-15

GCC 1366: Anti-Proliferative Response to NeoAdjuvant AIs in Overweight and Obese Patients

Phase NA Terminated

42 enrolled 13 charts

Breast Neoplasms

NCT02754752 2026-04-15

Electroacupuncture Therapy in Reducing Chronic Pain in Patients After Breast Cancer Treatment

Phase 2 Active not recruiting

Breast Neoplasms

NCT02876107 2026-04-15

Carboplatin and Paclitaxel With or Without Panitumumab in Treating Patients With Invasive Triple Negative Breast Cancer

Phase 2 Active not recruiting

Breast Neoplasms, Edema, Erythema, Inflammatory Breast Neoplasms, Triple Negative Breast Neoplasms

NCT03162627 2026-04-15

Selumetinib and Olaparib in Solid Tumors

Phase 1 Active not recruiting

Breast Neoplasms

NCT03168737 2026-04-15

18F-Fluoroazomycin Arabinoside PET-CT in Diagnosing Solid Tumors in Patients

Phase 1 Active not recruiting

BreastGastrointestinal

Breast Neoplasms, Colonic Neoplasms, Pancreatic Neoplasms

NCT03546972 2026-04-15

Diabetes Prevention Program With or Without Hunger Training in Helping to Lower Breast Cancer Risk in Obese Participants

Phase NA Active not recruiting

Carcinoma, Intraductal, Noninfiltrating, Obesity, Overweight

NCT03604315 2026-04-15

Serial Imaging of the Novel Radiotracer [^18F] FLuorthanatrace ([^18F] FTT) by PET/CTF

Phase 1 Recruiting

BreastGynecologic

Breast Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT03935282 2026-04-15

AH-HA

Phase NA Completed

645 enrolled 43 charts

BreastGastrointestinalGenitourinaryGynecologicLymphoid

Breast Neoplasms, Cardiovascular Diseases, Hodgkin Disease, Lymphoma, Non-Hodgkin, Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms, Health Behavior, Endometrial Neoplasms

NCT04852887 2026-04-15

DEBRA

Phase 3 Recruiting

Breast Neoplasms

NCT05042687 2026-04-15

Comparative Performance of Molecular Breast Imaging (MBI) to Magnetic Resonance Imaging (MRI) of the Breast in Identifying and Excluding Breast Carcinoma in Women at High Risk for Breast Cancer

Phase NA Recruiting

Breast Neoplasms

NCT05394259 2026-04-15

A Pilot Study to Assess the Clinical Utility of PYLARIFY PET-CT for Detecting Metastasis in Pancreatic Cancer, Hepatocellular Carcinoma and Breast Cancer

Phase 1 Recruiting

BreastGastrointestinal

Breast Neoplasms, Carcinoma, Hepatocellular, Pancreatic Neoplasms

NCT05664893 2026-04-15

CALHYS

Phase 1/2 Withdrawn

HER2 Negative Breast Cancer Not Immediately Operated

NCT06538389 2026-04-15

High Cannabidiol Plant Extract (BRC-001) to Improve Aromatase Inhibitor-Induced Arthralgia in Women With Breast Cancer

Phase 2 Suspended

Breast Carcinoma In Situ, Carcinoma, Intraductal, Noninfiltrating

NCT06638931 2026-04-15

ANTARES

Phase 2 Recruiting

BreastCNSEndocrineGastrointestinalGenitourinaryGynecologicHead & NeckNETOther solid neoplasmSarcomaThoracic

Urachal adenocarcinoma, Urachal cancer, Fibrolamellar hepatocellular carcinoma, Secretory breast carcinoma, Carcinoma, Ovarian Epithelial, Adrenal Gland Neoplasms, Anus Neoplasms, Biliary Tract Neoplasms, Carcinosarcoma, Carcinoma, Adenoid Cystic, Fallopian Tube Neoplasms, Fibrosarcoma, Gallbladder Neoplasms, Granulosa Cell Tumor, Hemangiosarcoma, Leiomyosarcoma, Mesothelioma, Neuroblastoma, Parathyroid Neoplasms, Penile Neoplasms, Sarcoma, Sarcoma, Kaposi, Osteosarcoma, Thyroid Neoplasms, Trophoblastic Neoplasms, Urethral Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms, Hepatoblastoma, Endodermal Sinus Tumor, Neuroectodermal Tumors, Primitive, Cholangiocarcinoma, Sertoli-Leydig Cell Tumor, Neurofibrosarcoma, Hemangioblastoma, Neuroendocrine Tumors

NCT07045311 2026-04-15

JS207 Combination Therapy in Triple-negative Breast Cancer

Phase 2 Recruiting

Triple Negative Breast Neoplasms

NCT07076485 2026-04-15

Shortening Adjuvant Photon and Proton Irradiation (SAPPHIRe-II): A 4 Cohort, Randomized, Phase II Multi-center Trial Evaluating Shorter Schedules of Adjuvant Regional Nodal Irradiation Among Women and Men With Node-positive and High-risk Node-negative Invasive Breast Cancer

Phase 2 Recruiting

Breast Neoplasms

NCT07198581 2026-04-15

ALLIANCE

Phase NA Recruiting

BreastGastrointestinal

Breast Neoplasms, Colorectal Neoplasms

NCT07216495 2026-04-15

Pilot Study of Aerobic Exercise During Immune Checkpoint Inhibitor Therapy in Early-Stage TNBC

Phase NA Recruiting

Aerobic Exercise

NCT07504770 2026-04-15

Surgical Glove

Phase NA Not yet recruiting

Breast Neoplasms

NCT07531836 2026-04-15

PREHAB-BC65

Phase NA Recruiting

Frailty, Breast Neoplasms, Sarcopenia

NCT07532096 2026-04-15

Extended Sentinel Lymph Node Biopsy With Methylene Blue Single Tracer Post-Neoadjuvant Therapy for Node-Positive Breast Cancer

Phase NA Not yet recruiting

Breast Neoplasms

NCT01127295 2026-04-14

PHACS

Phase 4 Completed

Breast Neoplasms

NCT01553903 2026-04-14

OXYTAM

Phase 4 Completed

Breast Neoplasms

NCT01612871 2026-04-14

MIRHO

Phase 4 Completed

Breast Neoplasms

NCT02311959 2026-04-14

MAPAM-01

Phase 3 Completed

Breast Neoplasms, Carcinoma in Situ

NCT04677816 2026-04-14

Impact of Vitamin D Supplementation on the Rate of Pathologic Complete Response in Vitamin D Deficient Patients

Phase 2 Recruiting

Vitamin D Deficiency, Triple Negative Breast Neoplasms

NCT04920708 2026-04-14

FAIM

Phase 2 Active not recruiting

Breast Neoplasms

NCT05609435 2026-04-14

Intervention to Improve the Delivery of Follow-up Care for Low-Risk Breast Cancer

Phase NA Completed

Breast Neoplasms

NCT07225309 2026-04-14

A Study of Meaning-Centered Therapy for Mexican Adults With Advanced Cancer

Phase NA Not yet recruiting

BreastGastrointestinalGenitourinaryHead & Neck

Breast Neoplasms, Prostatic Neoplasms, Thyroid Neoplasms, Colorectal Neoplasms

NCT07400523 2026-04-14

Ribociclib in Hormone Receptor-positive, HER2-negative Early Breast Cancer With Residual Disease After Neoadjuvant Chemotherapy

Phase 3 Recruiting

Breast Neoplasms

NCT07443943 2026-04-14

AIMSS-RPS

Phase 2 Recruiting

Breast Carcinoma In Situ